Companies: 10,795·Total market cap: $144.5T
Nuo Therapeutics, Inc.

Nuo Therapeutics, Inc.

AURXOTCHealthcare● Active
$1.00
$-0.16(-13.79%)
Market Cap$48408700
P/E Ratio
52W High$3.23
52W Low$0.8415
Overview

Nuo Therapeutics, Inc. (AURX) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · AURX · as of Jun 9, 2026

Key Statistics

EPS (TTM)$-0.05aurx eps ttm · aurx earnings per shareEarnings history
PE Ratio (TTM)aurx pe ratio ttm · aurx price to earningsPE Ratio deep dive
Revenue (TTM)$4.1Maurx revenue ttm · aurx annual revenueFull revenue history
Dividend YieldNo Dividenddoes aurx pay dividends · aurx dividend yieldDividend history
Shares Outstanding47.3Maurx shares outstanding · aurx floatShares outstanding history
Next EarningsJun 29, 2026Est.aurx earnings date · aurx next earningsEarnings history

Financial Snapshot

Full Financials
FY 2025Revenue$3.3M▲ +142.72% YoY
202320242025
nuo therapeutics, inc. revenue · aurx revenue 2025
FY 2025Net Income-$2.5M▼ 8.11% YoY
202320242025
nuo therapeutics, inc. net income · aurx profit 2025
FY 2025EPS$-0.05▼ 3.71% YoY
202320242025
aurx eps · nuo therapeutics, inc. earnings per share 2025
TTM:Revenue: $4.1MNet Income: -$2.4MEPS: $-0.05View income statement →

Stock Performance

Full History
1D-13.79%
1W-5.66%
1M-20.63%
3M-20.00%
YTD-49.24%
1Y-36.71%
5Y+75.44%

About Nuo Therapeutics, Inc.

CEODavid E. Jorden
IPO DateOct 24, 2017
Employees9
CountryUS
Websitenuot.com

Nuo Therapeutics, Inc. operates as a regenerative medicine company, specializing in the development, commercialization, and marketing of advanced cell-based technologies. These solutions are engineere…

what is nuo therapeutics, inc. · aurx stock overview · nuo therapeutics, inc. company profile · who is nuo therapeutics, inc. ceo · aurx OTC · nuo therapeutics, inc. headquarters · nuo therapeutics, inc. business segments

About Stock Overview & Key Data

Nuo Therapeutics, Inc. (AURX) is a Healthcare company in the Biotechnology industry, listed on OTC since Oct 24, 2017. As of the latest trading session, AURX stock price is $1.00, with a market capitalization of $48.4M. The stock has returned -36.71% over the past 12 months and -49.24% year-to-date.

In fiscal year 2025, Nuo Therapeutics, Inc. reported revenue of $3.3M. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Nuo Therapeutics, Inc. (AURX) stock price is $1.00. The stock is traded on OTC under the ticker symbol AURX. The 52-week range is $0.84 – $3.23.

AURX stock priceAURX quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 9, 2026Not investment advice